MDAI (Spectral AI Inc.) Rasio tanggungan utang jangka dawa marang modal

Logo korporat perusahaan Spectral AI (MDAI)

Spectral AI, Inc. (MDAI) generates revenue through subscriptions to its DeepView diagnostic software, while management remains focused on overcoming regulatory hurdles. The ratio of long-term debt to equity helps balance these aspects, and the current value of this metric is 0.00. The successful utilization of US government grants and strict adherence to strategy confirm a high level of confidence in the team.

Spectral AI, Inc. (MDAI): Utang jangka dawa marang modal saka 21.02.2024 nganti 28.10.2026
Produk merek Spectral AI

Investors use this ratio to assess the issuer's financial stability and debt load. For Spectral AI, Inc. (MDAI), which is scaling its DeepView system, balancing borrowed funds is critical while obtaining FDA clearances. The long-term debt-to-equity trend reflects the ratio of loans with a maturity exceeding one year to the company's market value. An increase in this index signals a risk of equity devaluation. The asset is categorized as a high-risk tech startup.

Pesaing utama

Rasio utang jangka dawa marang modal Abbott Labs|TMO (Thermo Fisher Corp) - Utang jangka dawa marang modal|Rasio tanggungan utang jangka dawa marang modal GE HealthCare Inc. (GEHC)|Utang jangka dawa marang modal MTD (Mettler-Toledo International)|Utang jangka dawa marang modal waters.com WAT|Utang jangka dawa marang modal TECH|BRKR: Tanggungan utang jangka dawa marang ekuitas|Utang jangka dawa marang ekuitas Azenta Life Sciences|VREX (Varex Imaging Corp.) - Rasio utang jangka dawa marang modal|Utang jangka dawa marang ekuitas SMLR (Semler Scientific, Inc.)|Kewajiban jangka dawa marang modal BFLY|MLAB (Mesa Labs) - Utang jangka dawa marang ekuitas|Rasio tanggungan utang jangka dawa marang modal Quantum-Si Inc. QSI|Rasio utang jangka dawa marang ekuitas Nanox (NNOX)|Rasio silihan jangka dawa marang modal Quanterix Inc QTRX|Utang jangka dawa marang modal MASS (908 Devices Inc.)|CV - Rasio tanggungan utang jangka dawa marang modal|MXCT (MaxCyte) - Utang jangka dawa marang modal|Rasio utang jangka dawa marang ekuitas Rapid Micro Biosystems, Inc.|SEER - Rasio utang jangka dawa marang ekuitas|Koefisien utang jangka dawa marang modal HYPR|Utang jangka dawa marang ekuitas FONR (FONAR Corporation)|Rasio utang jangka dawa marang ekuitas daxor.com (DXR)|VIVS: Utang jangka dawa marang modal|Kewajiban jangka dawa marang modal Aclarion Inc ACON|Akoya (AKYA) - Utang jangka dawa marang modal|THMO - Rasio utang jangka dawa marang modal|talis.bio - Utang jangka dawa marang modal|t2biosystems.com (TTOO) - Rasio tanggungan utang jangka dawa marang modal